在宫癌的情况下Pseudomyxoma Peritonei:微妙的发现与对管理和预后的影响
Sarita Kumari1, Suvidya Singh1
1Department of Gynaecologic Oncology National Cancer Institute All India Institute of Medical Sciences 110029, New Delhi, India.
Case reports in oncological medicine
|August 9, 2024
概括
皮瘤 (Pseudomyxoma peritonei,简称PMP) 是一种罕见的疾病,通常与胃肠道或卵巢瘤有关. 本报告详细介绍了一例与晚期宫内腺癌相关的PMP病例,通过手术治疗.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 妇科瘤学 妇科瘤学
背景情况:
- 伪瘤 (Pseudomyxoma peritonei,简称PMP) 的特征是粘膜和瘤植入物.
- PMP通常与尾,结肠或卵巢的粘膜瘤有关.
- PMP的预后影响根据其与良性或恶性瘤的关联而有所不同.
研究的目的:
- 报告一种罕见的PMP病例.
- 突出PMP与晚期宫内腺癌的相关性.
- 描述这种特定的PMP呈现的外科治疗方法.
主要方法:
- 案例报告. 情况报告.
- 手术管理. 手术管理.
- 病理学审查. 病理学审查.
主要成果:
- 在患有晚期内腺癌的患者中发现了PMP病例.
- 患者因这种情况而接受了手术干预.
- 组织学分析证实了PMP和宫内腺癌的粘膜性质.
结论:
- 状瘤 (Pseudomyxoma peritonei) 可能与晚期宫内腺癌相关.
- 在这种情况下,手术管理是PMP的可行选择.
- 进一步的研究可能会阐明由宫恶性瘤引起的PMP的特定机制和最佳治疗策略.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
239
相关概念视频
Esophageal Perforation-II: Clinical Manifestations and Management
54
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
54
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
